|Podcasts|July 22, 2021
Episode 87: Attacking Bladder Cancer From All Sides
Author(s)Elaine Quilici
Arthur Kuan, CEO of CG Oncology, talks about the present and future of bladder cancer therapies, and how he’s committed to making a difference.
Advertisement
Arthur Kuan, CEO of CG Oncology, discusses bladder cancer therapies and how his company is contributing to the fight.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Who Pays for Tariff Driven Input Cost Increases?
2
Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb
3
Pharmaceutical Executive Daily: Amplitude Therapeutics Partners with Eli Lilly
4
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
5